SCHEMBL7392894

SCHEMBL7392894

CC(C)[C@H](NCC1CCCCC1)C(=O)NCCCC(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CACNA1B Q00975 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.43
▸ KCNH2 Q12809 4/20 0.42
▸ SLC6A3 Q01959 3/20 0.41
▸ SCN5A Q14524 1/20 0.41
▸ EPHX1 P07099 1/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ BCHE P06276 1/20 0.40
▸ CTSL P07711 1/20 0.40
▸ FAAH O00519 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ VPS4B O75351 1/20 0.39
▸ VCP P55072 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7385281 0.86 CACNA1B (0.55) CACNA1BKCNH2SLC6A3SCN5AEPHX2
SCHEMBL7385278 0.86 CACNA1B (0.55) CACNA1BKCNH2SLC6A3SCN5AEPHX2
SCHEMBL7394742 0.83 CACNA1B (0.61) CACNA1BSLC6A3SCN5AEPHX2FAAH
SCHEMBL7394739 0.83 CACNA1B (0.61) CACNA1BSLC6A3SCN5AEPHX2FAAH
SCHEMBL7393942 0.81 CACNA1B (0.70) CACNA1BSLC6A3EPHX2FAAHCYP3A4
SCHEMBL7391813 0.79 CACNA1B (0.67) CACNA1BCTSL
SCHEMBL7391849 0.79 CACNA1B (0.52) CACNA1BSLC6A3SCN5AEPHX2FAAH
SCHEMBL7393762 0.79 CACNA1B (0.51) CACNA1BSLC6A3SCN5ACTSLRAB9A
SCHEMBL7392896 0.77 CACNA1B (0.53) CACNA1BALDH1A1KCNH2SLC6A3SCN5A
SCHEMBL7661290 0.77 CACNA1B (0.53) CACNA1BALDH1A1KCNH2SLC6A3SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458781-B1 BLOCKERS CALCIUM CHANNEL ANTAGONISTS FOR STROKES, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2002-10-01 — — US claimed
WO-1999055688-A1 SUBSTITUTED DIARYLALKYL AMIDES AS CALCIUM CHANNEL ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-11-04 — — WO claimed
US-6458781-B1 BLOCKERS CALCIUM CHANNEL ANTAGONISTS FOR STROKES, BRAIN DISORDERS WARNER-LAMBERT COMPANY 2002-10-01 — — US disclosed
WO-1999055688-A1 SUBSTITUTED DIARYLALKYL AMIDES AS CALCIUM CHANNEL ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1999-11-04 — — WO disclosed
Send feedback